Application Nr Approved Date Route Status External Links
ANDA090622 None Sublingual None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Buprenorphine Sublingual Tablets Is Indicated For The Treatment Of Opioid Dependence And Is Preferred For Induction. Buprenorphine Sublingual Tablets Should Be Used As Part Of A Complete Treatment Plan To Include Counseling And Psychosocial Support. Buprenorphine Sublingual Tablets, Contains Buprenorphine, A Partial Opioid Agonist, And Is Indicated For The Treatment Of Opioid Dependence And Is Preferred For Induction. Buprenorphine Sublingual Tablets Should Be Used As Part Of A Complete Treatment Plan That Includes Counseling And Psychosocial Support ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Buprenorphine Hydrochloride BUPRENORPHINE HYDROCHLORIDE ZINC100373348

Comments